SCHEMBL851824

SCHEMBL851824

N#CCCSC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432464-B1 NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS INNOVATION PHARMACEUTICALS INC (US) 2019-01-09 EP claimed
US-9610275-B2 Nitrile derivatives and their pharmaceutical use and compositions CELLCEUTIX CORPORATION (US) 2017-04-04 US claimed
CN-102438612-B Nitrile derivatives, their pharmaceutical use and compositions CELLCEUTIX CORP. (US) 2016-02-03 CN claimed
US-20130245062-A1 NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS CELLCEUTIX CORPORATION (US) 2013-09-19 US claimed
US-8338454-B2 Nitrile derivatives and their pharmaceutical use and compositions CELLCEUTIX CORPORATION (US) 2012-12-25 US claimed
US-20120189537-A1 NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS CELLCEUTIX CORPORATION 2012-07-26 US claimed
CN-102438612-A Nitrile derivatives, their pharmaceutical use and compositions CELLCEUTIX CORP 2012-05-02 CN claimed
EP-2432464-A2 NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS Cellceutix Corporation (US) 2012-03-28 EP claimed
US-20100298374-A1 NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS CELLCEUTIX CORPORATION (US) 2010-11-25 US claimed
WO-2010135170-A2 NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS CELLCEUTIX CORPORATION (US) 2010-11-25 WO claimed
WO-1998040368-A1 SYNTHESIS OF THIAZOLE DERIVATIVES ALBEMARLE CORPORATION (US) 1998-09-17 WO claimed
US-5731442-A Synthesis of thiazole derivatives ALBEMARLE CORPORATION (US) 1998-03-24 US claimed
EP-3018125-B1 NOVEL COMPOUND, ORGANIC CATION TRANSPORTER 3 DETECTION AGENT, AND ORGANIC CATION TRANSPORTER 3 ACTIVITY INHIBITOR SHIN NIPPON BIOMEDICAL LABORATORIES LTD (JP) 2020-08-05 EP disclosed
EP-2432464-B1 NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS INNOVATION PHARMACEUTICALS INC (US) 2019-01-09 EP disclosed
US-9745274-B2 Compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (JP) 2017-08-29 US disclosed
US-9745274-B2 Compound, organic cation transporter 3 detection agent, and organic cation transporter 3 activity inhibitor SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (JP) 2017-08-29 US disclosed
WO-1998040368-A1 SYNTHESIS OF THIAZOLE DERIVATIVES ALBEMARLE CORPORATION (US) 1998-09-17 WO disclosed
US-5731442-A Synthesis of thiazole derivatives ALBEMARLE CORPORATION (US) 1998-03-24 US disclosed
US-5731442-A Synthesis of thiazole derivatives ALBEMARLE CORPORATION (US) 1998-03-24 US disclosed
US-4942243-A Process for preparing N\"-[4-[[(2-cyanoethyl)thio]methyl]-2-thiazolyl]guanidine HANIL PHARMACEUTICAL IND., CO., LTD. (KR) 1990-07-17 US disclosed